KZIA
Kazia TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Primary-source evidence supports a cautious upside case built around several real 2026 shots on goal: Q2 FDA path-forward feedback in GBM, 2H neuro-oncology readouts, and 2H breast-cancer efficacy/biomarker updates. March 2026 materials also cited roughly US$46 million of cash, no debt, and runway into 2029 excluding additional or expanded trials, which helps support continued execution [#IR-2026-03-27].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -4.8.
What can break
Clinical evidence remains early and fragile, with the January 2026 TNBC update based on a very small number of patients and no mature randomized efficacy readout yet.
Momentum
79
Value
41
Sentiment
32
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $12.00 · Bull $19.00 · Bear $5.50
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $27.80
Why
Momentum79 · Δ7d -4.8
Value41 · Δ7d +0.0
Sentiment32 · Δ7d -1.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
79
26% active weight
Current posture
7d trendFlat
Δ7d
-4.8
Δ21d
-13.0
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
32
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
+3.7
Why this grade
Composite grade D. Momentum 78.8 / Value 41.1 / Sentiment 32.2
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$153.6M
Beta
1.79
Shares Out
11.34M
P/E (TTM) · Derived
-3.7
P/S (TTM)
802.17
P/FCF (TTM) · Derived
-2.26
Rev YoY
-96.3%
EPS YoY
+96.8%
Gross Margin
-
Op Margin
-21258.8%
Net Debt
-$2.59M
Current Ratio
2.87
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology